The University of Texas Health Center at Tyler
Clinical research site in Tyler, Texas · 11937 US HIGHWAY 271, TYLER, TX 75708-3154 · (903) 877-5139
As of September 2026, 12 paid clinical trials are recruiting at The University of Texas Health Center at Tyler in Tyler, Texas. Active studies at this site cover conditions such as Carcinoma, Non-Small-Cell Lung, Crohn Disease and Extensive Stage Small Cell Lung Cancer (ES-SCLC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at The University of Texas Health Center at Tyler (12)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Get new-trial alerts for The University of Texas Health Center at Tyler
We'll email you whenever a new clinical trial starts recruiting at this research site in Tyler, TX. Unsubscribe anytime.
More research sites in Tyler
- Texas Oncology - Northeast Texas (23 trials)
- Tyler Research Institute, LLC (16 trials)
- Tyler Research Institute (8 trials)
- CHRISTUS Trinity Mother Frances Health System (7 trials)
- Texas Oncology - Northeast (5 trials)
- Texas Oncology - Tyler (5 trials)
- Texas Oncology (4 trials)
- Texas Oncology, P.A. - Tyler (4 trials)
- The University of Texas Health Science Center at Tyler (4 trials)
- Tyler Retina Consultants (4 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.